Accelerating Expansion Across Human and Veterinary Health Through Innovation and Strategic Collaboration BRUSSELS , May 15, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology , a global leader in in-vitro diagnostic (IVD) technologies, is pleased to announce its participation in three major international

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products, today announced the closing of its initial public offering

Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products, today announced the pricing of its initial public offering